TARA TAYLOR: Open Payments
NPI 1720637424 · TUKWILA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 14 payments from 6 companies in 2025. Trend: 2023 $468 · 2024 $747 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $156 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| Lundbeck LLC | 1 | $31 |
| ABBVIE INC. | 1 | $23 |
Products named: ARISTADA, CAPLYTA, ABILIFY MAINTENA, LYBALVI, INGREZZA, REXULTI, VIVITROL, MAVYRET.
Industry payments across WA — which companies pay providers there.
